en
Scientific article
English

Denosumab in postmenopausal women with osteoporosis and diabetes: Subgroup analysis of FREEDOM and FREEDOM extension

Published inBone, vol. 134, 115268
Publication date2020
Abstract

Diabetes and osteoporosis occur frequently in older adults and are both associated with increased fracture risk. Denosumab treatment reduced new vertebral, nonvertebral, and hip fractures over 3 years, with continued low fracture incidence for up to 10 years in postmenopausal women with osteoporosis. However, its effects in diabetic subjects with osteoporosis have not yet been investigated.

Keywords
  • Diseases and disorders of/related to bone
  • Osteoporosis
  • Clinical trials
  • Therapeutics antiresorptive
Funding
  • European Commission - Training network for research into bone Fragility In Diabetes in Europe – towards a personaLised medIcine apprOach [860898]
Citation (ISO format)
FERRARI, Serge Livio et al. Denosumab in postmenopausal women with osteoporosis and diabetes: Subgroup analysis of FREEDOM and FREEDOM extension. In: Bone, 2020, vol. 134, p. 115268. doi: 10.1016/j.bone.2020.115268
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1873-2763
247views
2downloads

Technical informations

Creation05/12/2020 3:03:00 PM
First validation05/12/2020 3:03:00 PM
Update time03/15/2023 10:06:31 PM
Status update03/15/2023 10:06:31 PM
Last indexation10/19/2023 12:55:33 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack